The role of m 6 A methylation of RNA has remained elusive for decades, but recent technological advances are now allowing the mapping of the m 6 A methylation landscape at nucleotide level. This has spurred an explosion in our understanding of the role played by RNA epigenetics in RNA biology. m 6 A modifications have been tied to almost every aspect of the mRNA life cycle and it is now clear that RNA virus genomes are subject to m 6 A methylation. These modifications play various roles in the viral replication cycle. This review will summarize recent breakthroughs concerning m 6 A RNA modification and their implications for cellular and viral RNAs.
INTRODUCTION
The concept of a modified RNA nucleoside emerged 60 years ago with the isolation of a fifth nucleotide following analysis of soluble RNA from yeast [1] . N6-methyladenosine, or m 6 A, was then discovered in the 1970s in a wide range of cellular mRNAs but also in the mRNAs of the viruses vaccinia, Rous sarcoma and influenza [2] [3] [4] [5] [6] [7] [8] .
To date more than 100 distinct chemical modifications to RNA have been characterized, most of which are found to be abundant in non-coding RNA such as tRNA, rRNA and snRNA, and paramount in maintaining their functions in translation and splicing [9] . However, recent studies established that one of the most abundant modifications, m 6 A, can also be detected internally in mRNAs, influencing their metabolism and function of mRNAs [9] . Overall, this multitude of RNA modifications highlights the importance of RNA epigenetics or the epitranscriptome. m 6 A RNA modifications are dynamically regulated by methyltransferases or writers, and demethylases or erasers, and exert their function by either directly being recognized by m 6 Abinding proteins or readers, or indirectly by tuning the structure of the modified RNA to regulate RNA reader-protein interactions. Multiple m 6 A-specific readers have been identified that affect the metabolism and function of m 6 A-RNA in various ways, as discussed below [10] [11] [12] [13] [14] [15] [16] . In mammalian cells, the N6-methylation of adenosine is catalysed by a 200 kDa complex consisting of the methyltransferases Methyltransferase-Like Protein 3 (METTL3), METTL14 and the associated protein Wilms Tumor 1 Associated Protein (WTAP) [17] [18] [19] [20] [21] [22] . Although it cannot be excluded that uncharacterized writers contribute to m 6 A methylation, mouse embryonic stem cells lacking both METTL3 and METTL14 display up to 99 % reduction in m 6 A signals [23, 24] . Most of these mammalian m 6 A sites are found within the consensus RRm 6 ACH (R=Guanosine or Adenosine, H=Adenosine, Cytidine or Uridine), which is consistent with the binding motifs identified for METTL14, METTL3 and WTAP [19] . However, despite this strong consensus, only a fraction of all possible RRACH sites are found methylated in vivo, which further highlights the dynamic nature of m 6 A modification. m 6 A modification can be removed by two demethylases, Fat mass and Obesity-associated protein (FTO) and AlkB Homolog 5 (ALKBH5), both of which use different mechanisms to revert m 6 A to A [25, 26] . Finally, m 6 A can also be detected on viral RNA and influences virus infection and production [27] [28] [29] [30] [31] .
Unravelling the m 6 
A methylome
The dissection of the m 6 A landscape has been impaired by the fact that m 6 A bases cannot be detected directly by sequencing, as they do not change the base pairing properties and are indistinguishable from regular bases by reverse transcription. Recently, new methods based on m 6 A immunoprecipitation or modification selective RNA chemistry to isolate modified RNA fragments, coupled with highthroughput sequencing, namely m 6 A-seq and MeRIP-seq, have identified thousands of hundred-nucleotide fragments containing the modification in the transcriptomes of mammalian cells [11, 32] . A limitation of these antibody-based methods is the large amount of RNA material required, precluding experiments at single cell level or with low abundancy samples. The quality of the antibodies used is also critical, with evidence for artefactual enrichment of mRNA fragments lacking m 6 A. In addition, m 6 A antibodies may have RNA sequence and structure bias [22] .
These approaches were therefore further refined, initially by implementing the use of methyltransferase-deficient cells and ligation-based strand-specific library preparation [22] . While in yeast, around only 50 % of the m 6 A peaks are sensitive to depletion of the unique yeast methyltransferase [22] ; in human cells, the genetic manipulation of methyltransferases and demethylases resulted in the expected changes in m 6 A peaks [19, 22, 23, 25] and thousands of m 6 A peaks overlap the binding sites for m 6 A-modifying enzymes in vivo [12, 21] .
Finally, single nucleotide-resolution m 6 A mapping can now be achieved by crosslinking the antibody: RNA complexes through the incorporation of 4-thiouridine and determining the site of crosslink in enriched RNA fragments [33] [34] [35] . These methods have resulted in detection of over 10 000 m 6 A sites in the mammalian transcriptome, revealing enrichment in the 3¢ untranslated region (UTR) and near stop codons and, satisfyingly, the m 6 A methylomes of different human cell lines are highly overlapping [11, 23] .
Therefore, high-confidence mapping of m 6 A sites can be achieved using these complementary approaches. However, most current approaches dissecting the m 6 A methylome lack quantitative information. Indeed the impact of RNA modification depends on both function of individual m 6 A sites and the fraction of transcripts that have been modified. To address these stoichiometry issues, several methods have been developed to quantify the level of m 6 A modification, either at one given locus or on a genome-wide level [36, 37] . A modification with mechanistic studies linking it to mRNA stability, splicing, translational efficacy; primicroRNA processing as summarized in Fig. 1 [10, 13-15, 20, 24, 38] . m The presence of m 6 A reduces base pair stability, and methylated transcripts are less structured both in vitro and in vivo than their demethylated counterparts [22, [39] [40] [41] . The accumulation of m 6 A:U pairs can result in destabilizing AU-rich regions and promoting the recruitment of Heterogeneous Nuclear Ribonucleoprotein C (hnRNPC) by exposing a Uridine-rich sequence, whose accessibility is otherwise hindered in the unmethylated transcripts [12] . Similarily, m 6 A modifications also alter local RNA structure to allow the binding of hnRNPG [42] . By stimulating the binding of these two reader proteins, m 6 A modifications therefore regulate alternative splicing [12, 42] . Furthermore, increased m 6 A levels in response to FTO depletion result in higher affinity for the splicing factor SRSF2, bolstering the links with RNA splicing [43] . m 6 A RNA modifications impact on RNA stability
Reader proteins from the YTH domain family, YTHDF1-3, can act as m 6 A readers to regulate mRNA decay. Depending on the cellular context, YTHDF2 binding to m 6 A transcripts results in their re-localization from the pool of ribosome-associated translatable transcripts to cellular RNA decay sites such as P-bodies, where the decapping machinery and 5¢ to 3¢ exonucleases accumulate. YTHDF2 acts as an adaptor protein in this process, as its carboxy-terminal domain binds to methylated mRNAs while its amino-terminal domain mediates localization to P-bodies [14, 38] (Fig. 1 ). m 6 A methylation adjacent to binding sites for Hu antigen R (HuR), an RNA-binding protein that binds AU-rich elements to stabilize mRNAs, reduces HuR binding leading to increased RNA instability [20] . m 6 A RNA modifications impact on mRNA translation m 6 A moieties can promote translation when located within 5¢ UTRs or near stop codons and in the 3¢ UTR. In the 5¢ UTR, the m 6 A-induced ribosome engagement site (MIRES) can bind directly to the translation factor eIF3 to recruit 43S internally and initiate cap-independent translation [13] ( Fig. 1) . In contrast, m 6 A located near stop codons or in the 3¢ UTR is recognized by the reader protein YTHDF1, which then interacts with eIF3 and other ribosome-associated proteins to stimulate cap-dependent ribosome loading [15] . This has also led to the exciting hypothesis that m 6 A-driven translation could mediate specific stress-induced translational responses [13, 38] . Indeed upon heat shock the cytoplasmic reader YTHDF2 can relocate to nuclear speckles, where it protects the 5¢ UTR of stress-induced transcripts from demethylation by the eraser FTO, resulting in increased translation of these transcripts [38] . m 6 A RNA modifications impact on cellular functions All the effects described above suggest the existence of previously unknown RNA regulons involved in combinatorial control of gene expression [14, 15, 38] . This further impacts on several cellular functions, with a strong body of evidence connecting m 6 A modification with mammalian embryonic stem cell fate and the regulation of pluripotency factors, and also with X chromosome inactivation, the response to UVinduced DNA damage, metabolic diseases and the stability of the mammalian circadian clock [20, A modifications, for example influenza virus [6] , Rous sarcoma virus [8] or simian virus 40 [48] , the function of these modifications and whether the viruses alter the cellular m [28, 29, 31] . These sites mostly cluster within three regions of the genome, the 3¢ UTR defining the U3/NF-kB and TAR clusters, the nef and U3/nef overlap cluster and the env/rev overlap cluster. In addition, the occurrence of m 6 A modifications on some specific loci in individual studies may reflect a dependency of the m 6 A landscape on the experimental approach. For instance, Kennedy et al. identified two m 6 A sites in the HIV-1 primary isolate JR-CSF but not in the laboratory isolate NL4-3 or the primary isolate BaL [28] . Interestingly one of these coincides with a novel adenosine residue present only in JR-CSF, and further studies should aim at identifying this unique residue as the exact site of m 6 A modification. In addition, Tirumuru et al. identified several m 6 A peaks in the 5¢ UTR leader sequence, the gag gene, the Rev-response element (RRE) and in the rev gene [31] . A modifications located in the U5/TAR and gag region of the HIV-1 NL4-3 genomic RNA (gRNA) in infected Jurkat and primary CD4 +T cells, which is not addressed in the two other studies. Mechanistic analysis further linked the recognition of this site by the cellular YTHDF1-3 proteins to a repression of the reverse transcription of the viral gRNA, pointing to a cellular anti-viral mechanism which could explain differences in infectivity levels between laboratory strains and cultivable models. This observation may be of particular importance, as m 6 A modification of viral RNA had been previously described as a cellular innate immune response escape mechanism, suggesting a wider impact on viral A motifs within the viral mRNAs 3¢ UTRs interacting with YTDH1-3, and in particular YTDH2, contribute to the stabilization of viral mRNAs and are thus linked to strong expression of viral proteins in the CD4+T CEM-SS cell line [28] .
Finally, Lichinchi et al. proposed another mechanism involving m 6 A modification of two adenosine residues in the stem-loop II region of HIV-1 RRE enhancing the binding of Rev protein to the HIV-1 RNA, its nuclear export and subsequently increasing viral replication. Site-directed mutagenesis of those adenosines in the HIV-1 LAI strain showed a dramatic decrease in viral replication, confirming that the effect seen by the inhibition of the cellular methyltransferases was mainly due to an effect on viral RNA rather than on cellular RNAs. The authors also showed the evolutionary benefit of this mechanism by highlighting the conservation of those two residues across 2501 HIV-1 sequences isolated from infected humans [29] . A mapping for different members of the Flaviviridae family highlighted conserved m 6 A modifications within the regions coding for the non-structural proteins NS3 and NS5, and within 3¢ UTR sequences, that could suggest conserved functions.
In addition, while the activity of writers METTL3 and 14 is associated with a restriction of viral replication, the erasers FTO and ALKBH5 exert an opposite effect in infected cell culture, suggesting a negative regulation of viral replication by m 6 A modification. Further mechanistic studies identified that (i) the YTHDF proteins mediate this m 6 A-associated regulation of the viral life cycle and (ii) this effect is due to modification of the viral genomic RNAs rather than to changes in the m 6 A cellular methylome, as discussed in more detail below.
Unlike the effect described for cellular mRNAs, Gokhale et al. proposed that m 6 A modification seems to have no effect on the stability or the translation efficiency of HCV RNA [27] . However, the authors identified a direct interaction between the m 6 A-modified HCV RNA and YTHDF proteins, and showed an inverse correlation with its packaging into newly produced virions in the cytoplasm of infected cells (Fig. 2) . The comparison between the methylome of the HCV RNA and YTHDF binding sites, as identified by PAR-CLIP analysis, revealed a unique region consisting of m 6 A sites clustered within the envelope E1 coding region, both containing m 6 A modifications and bound by YTHDF proteins, as responsible for this molecular switch from one step of the viral life cycle to the other. This E1 coding region cluster displays a greater affinity for all YTDH when methylated, which in turn prevents the binding of HCV Core protein to the viral RNA and results in impaired virion packaging. Corroborating these results, the authors also showed a very low occurrence of m A modification. Nevertheless, all the flavivirus RNAs contain m 6 A sites within the NS5 coding regions and the 3¢ UTRs. The functional significance of this observation remains to be discussed, as the analysis was carried out in infected human hepatoma-derived Huh7 cells at different time-points (24 to 48 h), without evidence of conducting the analysis at the relevant time point for each virus [27] . Furthermore, the use of poly(A)+RNA selection for the MeRIP experiment, and the viral RNAs studied not containing poly(A) tails, may have resulted in some bias.
In contrast to these results, Lichinchi et al. identified 12 sites of m 6 A modification in the ZIKV strain MR766 RNA in HEK 293T cells and suggested that these modifications result in the destabilization of viral RNA and impact on viral replication. The binding of YTHDF2 to m 6 A sites in the ZIKV 3¢ UTR results in the relocalization of the m 6 A modified viral RNA with the cellular mRNA decay machinery. Furthermore, the absence of m 6 A modification in YTHDF2 knockout cells results in increased viral protein expression and viral replication [27, 30] .
Interestingly, as shown for HIV-1, the locations of m 6 A modifications identified for ZIKV RNA in the two studies do not perfectly overlap, potentially reflecting the use of different viral strains and cellular models. Bolstering this observation, Gokhale et al. showed important differences between the two ZIKV strains investigated despite the use of the same cell line [27] . The existence of such variability in the topology of the m 6 A modifications of viral RNA could markedly reflect its importance as a dynamic, given its potential to be a reverted, versatile tool of adaptation to the host. However, this strain-related variability of m 6 A topology also demonstrates the extent to which such studies must initially be primarily comparative rather than mechanistic, and perhaps most of the divergent m 6 A modifications are unlikely to be of biological relevance in these simple ex vivo in vitro models. Ideally, this analysis of the viral RNA m 6 A landscape should be carried out on material isolated from clinical samples rather than viral RNA synthesized by replication in permissive cell lines. The quintessential principle of epigenetic markings, as a tool of finely tuned adaptation to a defined environment -or host when in regard to viruses -thus resides in both its vertical conservation and its versatility. While HIV-1 infection in Jurkat cells and primary CD4+T cells does not result in significant differences in the abundance of total m 6 A peaks mapped to the human transcriptome compared to uninfected cells, analysis of the preferred motifs showed a slight increase of the frequency of the consensus RRACH motif and a corresponding decrease of the GGACU motif frequency [31] . Further gene ontology analysis of the m 6 A-modified cellular genes associates this redistribution of m 6 A sites with functional clustering in pathways involved in viral infection and in wider processes such as metabolism, the immune system and multicellular organismal processes and development. In contrast, using a different analytical approach, Lichinchi et al. identified 56 cellular gene transcripts specifically methylated following HIV-1 infection of another T-cell line, MT4 cells [29] . Interestingly, 19 of these have previously been associated with HIV replication and promote viral replication or directly interact with viral proteins [29] .
In addition, changes in the distribution of m 6 A peaks across the 5¢ UTR, CDS, 3¢ UTR and intronic sequences for these HIV-1-specific cellular methylated transcripts, when compared to total cellular mRNA, are reported as 17.5, 66, 14.4 and 2.1 % compared to 13.4, 41, 31.6 and 14 %, respectively. This suggests that these m 6 A modifications may exert functions in RNA splicing and translation rather than in RNA stabilization. Furthermore, HIV-1 infection results in the enrichment of MGACK m 6 A motifs in cellular motifs (where M=Adenosine or Cytidine and K=Guanosine or Uridine), mimicking the changes observed for viral RNA.
ZIKV infection also results in changes in the distribution of m 6 A modification, with an increase within the 5¢ UTR of the host transcripts and a corresponding decrease within the 3¢ UTR regions, suggesting an effect on cellular mRNA splicing, stabilization and translation [30] . Analysis of the consensus sequence further showed a switch in motif usage from RAACH over RGACH following ZIKV infection. Gene ontology analysis revealed that both the gained and lost m 6 A modifications are linked to immune-related pathways, which may lead to the suppression of immune surveillance systems or disturb other cellular processes to ensure viral replication [30] .
CONCLUSIONS AND PRACTICAL CONSIDERATIONS
Taken together, these studies demonstrate that m 6 A RNA modification of viral RNA is likely to illustrate a broad range of adaptive host-pathogen interactions at all steps of the viral life cycle. The first three studies describe three different mechanisms involved in HIV-1 viral fitness that are described as modulated by m 6 A modification of the viral mRNA and genomic RNA, respectively [28, 29] and [31] . This illustrates the potential of the study of this mechanism in terms of both broadening and enhancing our understanding of host-pathogen interactions following viral infection. However, beyond the renewed enthusiasm for RNA epigenetics in microbiology, the converse effects of m 6 A modification of HIV-1 RNAs at different steps of the viral life cycle indicate the need for more systemic and dynamic approaches in a physiologically relevant cellular context if we are to gain a comprehensive and translatable knowledge of the functionality of this epitranscriptomic event. Two additional studies focussing on Flaviviridae provide convincing examples of absolute cytoplasmic m 6 A modification of viral genomic RNAs [27] and [30] . While reporting novel and unique mechanisms of regulation of the viral replication of HCV and ZIKV, those publications also highlight the obvious need for a standardized dynamic approach to the investigation of viral RNA m 6 A modification following infection. This should also prompt further studies to determine the functional relationships between different viral systems and the m 6 A epitranscriptome. This is also relevant for viruses such as influenza virus or SV40, which were found to contain m 6 A modification in the initial studies that discovered m 6 A residues.
The recent advances in RNA sequencing and commercialization of the m 6 A antibody have made the study of modifications of the m 6 A landscape of viral and cellular genomes at the nucleotide level a readily available and straightforward process. The non-exhaustive list suggested in Table 1 recapitulates the practical approaches that could be used for the standard investigation of this event, also relevant in many types of biological process. For technical reasons and perhaps financial impediments, complete investigations cannot be carried out in a systematic manner in different cellular models or using a variety of viral strains. However, the functional mechanisms discovered should be validated and addressed from a dynamic point of view, bearing in mind that comparison with non-replicative models may also broaden our general understanding. Finally, key technological improvements in the near future should enable a move from mapping the epitranscriptome to understanding the biological function of individual modifications. The implementation of CRISPR-based genome editing will enable specific alteration of single m 6 A sites to determine the biological function of specific modifications, helping to unravel new functions for m 6 A modification in viral replication. A editing machinery or overexpressing these components.
(ii) Subcellular localization analysis of viral proteins, replication complexes and identified m 6 A readers to illustrate the spatio-temporal dynamic of these interactions, contributing to an integrated understanding of this new layer of virus-host interactions.
